Efficacy and Safety of Tranexamic Acid in Pediatric Trauma: A Systematic Review and Meta-Analysis
The Journal of Pediatric Pharmacology and Therapeutics · 2026-06 · 31 (3) · 347-365
DOI: 10.5863/jppt-25-00083 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Pediatric Pharmacology and Therapeutics, 2026-06. Verfasst von Mohammed Alsabri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department (MA), Althawara Modern General Hospital, Sanaa, Yemen. Die Arbeit nennt 110 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
OBJECTIVE Tranexamic acid (TXA) is a widely used antifibrinolytic agent in surgical and trauma settings in adults. This study aimed to evaluate the efficacy and safety of TXA in pediatric trauma patients across various clinical outcomes. METHODS A comprehensive literature search was conducted across 4 databases. We included clinical trials and observational studies that reported the use of TXA in pediatric trauma patients (aged ≤18 years). Data extraction and risk-of-bias assessment were performed by independent reviewers. Meta-analyses were conducted with RStudio software. RESULTS A total of 12 studies (2 randomized controlled trials [RCTs] and 10 observational) involving 66,398 pediatric trauma patients were included. Tranexamic acid was not significantly associated with reduction in hospital mortality (OR = 1.06; 95% CI, 0.32–3.45) but was associated with significantly shorter hospital stays (mean difference [MD] = −1.49; 95% CI, −2.43 to −0.56). The need for emergency mechanical ventilation was higher among the TXA group (OR = 4.29; 95% CI, 2.52–7.31), whereas the need for mechanical ventilation at discharge was lower (OR = 0.23; 95% CI, 0.08–0.64). Tranexamic acid use did not significantly alter the risk of thromboembolic events (OR = 0.72; 95% CI, 0.19–2.79) or poor neurological outcomes (OR = 2.51; 95% CI, 0.86–7.35). CONCLUSION Tranexamic acid may reduce hospital length of stay in pediatric trauma patients, with inconsistent effects on mortality and adverse events. Its use should be individualized based on injury severity and resource availability. Further high-quality research is needed to confirm these findings and clarify the role of TXA in pediatric trauma care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Emergency Department (MA), Althawara Modern General Hospital, Sanaa, Yemen.
- Pediatric Emergency Department (MA), Department of Pediatrics, St. Christopher's Hospital, Philadelphia, PA.
- Faculty of Medicine (YAM), Al-Azhar University-Gaza, Gaza, Palestine.
- Department of Diagnostic and Interventional Radiology (AAA), Damanhour Teaching Hospital, General Organization for Teaching Hospitals and Institutes, Damanhour, Egypt.
- All India Institute of Medical Sciences (SR), Bhubaneswar, India.
- Faculty of Medicine (MAK), Cairo University, Cairo, Egypt.
Zitieren
APA
Alsabri, M., Mahmoud, Y. A., Aboali, A. A., Rath, S., Khalifa, M. A., Abdul-Hafez, H. A., & Tariq, A. (2026). Efficacy and Safety of Tranexamic Acid in Pediatric Trauma: A Systematic Review and Meta-Analysis. The Journal of Pediatric Pharmacology and Therapeutics, 31(3), 347-365. https://doi.org/10.5863/jppt-25-00083
Vancouver
Alsabri M, Mahmoud YA, Aboali AA, Rath S, Khalifa MA, Abdul-Hafez HA, et al. Efficacy and Safety of Tranexamic Acid in Pediatric Trauma: A Systematic Review and Meta-Analysis. The Journal of Pediatric Pharmacology and Therapeutics. 2026;31(3):347-365. doi:10.5863/jppt-25-00083
BibTeX
@article{Alsabri2026,
author = {Alsabri, Mohammed and Mahmoud, Yahya A and Aboali, Amira A and Rath, Shree and Khalifa, Mostafa A and Abdul-Hafez, Hamza A and Tariq, Ammarah},
title = {Efficacy and Safety of Tranexamic Acid in Pediatric Trauma: A Systematic Review and Meta-Analysis},
journal = {The Journal of Pediatric Pharmacology and Therapeutics},
year = {2026},
volume = {31},
number = {3},
pages = {347--365},
doi = {10.5863/jppt-25-00083}
}
EUVIMED